FdaApplication
NDA 020080
Identifiers
- fda_app_no: NDA020080
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1992-12-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMITREX | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;SUBCUTANEOUS |
| IMITREX STATDOSE (AUTOINJECTOR) | SUMATRIPTAN SUCCINATE | EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) | SOLUTION;SUBCUTANEOUS |
| IMITREX STATDOSE (AUTOINJECTOR) | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | SOLUTION;SUBCUTANEOUS |
3 products